OKYO Pharma OKYO
NASDAQ OKYO
$1.54 +0.17 (+12.41%)
At close: Oct 21, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Share-based Compensation (2025 - 2026)

Updated

OKYO Pharma's Share-based Compensation was $870,271 in the quarter ended Mar 31, 2026, up 364.0% from the prior quarter.

Analysis

OKYO Pharma (OKYO) Share-based Compensation (2025 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, Share-based Compensation at OKYO Pharma came in at $1.61 million, up 118.4% from the prior year.

  • Share-based Compensation shows a five-year compound annual growth rate of 23.9% (years ended Mar 2021 to Mar 2026).
  • In earlier years, Share-based Compensation was $734,989 in the year ended Mar 31, 2025, $1.12 million in the year ended Dec 31, 2024 (-12.8%), $1.29 million in the year ended Dec 31, 2023 and $1.74 million in the year ended Mar 31, 2022 (+215.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 458.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 166.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 231.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 249.00 Mn
10 OKYO Pharma 1.03 Bn 999.20 Mn - 870,271.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 870,271.00
Dec 31, 2025 187,569.00
API Access

OKYO Pharma Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OKYO&period=max&api_key=YOUR_API_KEY